Contents: Gérard Jaouen Nils Metzler-Nolte : Introduction Stéphane GIBAUD and Gérard JAOUEN:
Arsenic - based drugs: from Fowler's solution to modern anticancer chemotherapy Ana M. Pizarro
Abraha Habtemariam and Peter J. Sadler : Activation Mechanisms for Organometallic Anticancer
Complexes Angela Casini Christian G. Hartinger Alexey A. Nazarov Paul J. Dyson :
Organometallic antitumour agents with alternative modes of action Elizabeth A. Hillard Anne
Vessières Gerard Jaouen : Ferrocene functionalized endocrine modulators for the treatment of
cancer Megan Hogan and Matthias Tacke : Titanocenes - Cytotoxic and Anti-Angiogenic
Chemotherapy Against Advanced Renal-Cell Cancer Seann P. Mulcahy and Eric Meggers :
Organometallics as Structural Scaffolds for Enzyme Inhibitor Design Christophe Biot and Daniel
Dive : Bioorganometallic Chemistry and Malaria Nils Metzler-Nolte : Biomedical applications of
organometal-peptide conjugates Roger Alberto : Organometallic Radiopharmaceuticals Brian E.
Mann : Carbon Monoxide - an essential signaling molecule.
